Cargando…
Drug-induced resistance evolution necessitates less aggressive treatment
Increasing body of experimental evidence suggests that anticancer and antimicrobial therapies may themselves promote the acquisition of drug resistance by increasing mutability. The successful control of evolving populations requires that such biological costs of control are identified, quantified a...
Autores principales: | Kuosmanen, Teemu, Cairns, Johannes, Noble, Robert, Beerenwinkel, Niko, Mononen, Tommi, Mustonen, Ville |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491903/ https://www.ncbi.nlm.nih.gov/pubmed/34555024 http://dx.doi.org/10.1371/journal.pcbi.1009418 |
Ejemplares similares
-
Understanding cellular growth strategies via optimal control
por: Mononen, Tommi, et al.
Publicado: (2023) -
Strong selective environments determine evolutionary outcome in time‐dependent fitness seascapes
por: Cairns, Johannes, et al.
Publicado: (2022) -
Contrasting the impact of cytotoxic and cytostatic drug therapies on tumour progression
por: Anttila, Jani V., et al.
Publicado: (2019) -
Diaphragmatic lipoma; A benign condition necessitating an aggressive management
por: Baram, Aram, et al.
Publicado: (2019) -
Spatial structure governs the mode of tumour evolution
por: Noble, Robert, et al.
Publicado: (2021)